The termination of Seguro Popular: impacts on the care of high-cost diseases in the uninsured population in Mexico by Luis Javier Cortés-Adame, Octavio Gómez-Dantés

Get full text

Geographic trends in asthma risk among children and adolescents across climate zones in Australia, 2004–2018 by Jialu Wang, Javier Cortes-Ramirez, Wenbiao Hu

Get full text

Patterns of immune evasion in triple-negative breast cancer and new potential therapeutic targets: a review by Lucía Serrano García, Beatriz Jávega, Antonio Llombart Cussac, Antonio Llombart Cussac, Antonio Llombart Cussac, María Gión, José Manuel Pérez-García, José Manuel Pérez-García, Javier Cortés, Javier Cortés, Javier Cortés, María Leonor Fernández-Murga

Get full text

Obesity, overweight and breast cancer: new clinical data and implications for practice by Laura García-Estévez, Laura García-Estévez, Marta González-Rodríguez, Isabel Calvo, Alberto Orta, María Gión, Gema Moreno-Bueno, Gema Moreno-Bueno, Gema Moreno-Bueno, José Manuel Pérez-García, José Manuel Pérez-García, José Manuel Pérez-García, Javier Cortés, Javier Cortés, Javier Cortés

Get full text

Q-TWiST Analysis of Sacituzumab Govitecan vs. Chemotherapy in Previously Treated Patients with HR+/HER2− Metastatic Breast Cancer by Hope S. Rugo, Aditya Bardia, Peter Schmid, Sara M. Tolaney, Anandaroop Dasgupta, Ankita Kaushik, Wendy Verret, Marine Gosset, Adam Brufsky, Javier Cortés, Frederik Marmé

Get full text

Single-Cell RNA Sequencing on Formalin-Fixed and Paraffin-Embedded (FFPE) Tissue Identified Multi-Ciliary Cells in Breast Cancer by Silvia González-Martínez, José Palacios, Irene Carretero-Barrio, Val F. Lanza, Mónica García-Cosío Piqueras, Tamara Caniego-Casas, David Hardisson, Isabel Esteban-Rodríguez, Javier Cortés, Belén Pérez-Mies

Get full text

Advancing breast cancer therapy in the era of molecular diagnostics by Maria Grazia Carnevale, Riccardo Ray Colciago, Maria Carmen De Santis, Laura Cortesi, Cinzia De Marco, Antonio Marra, Andrea Vingiani, Franco Nolè, Giuseppe Curigliano, Giancarlo Pruneri, Antonio Llombart-Cussac, Serena Di Cosimo, Javier Cortes

Get full text

In silico decrypting of the bystander effect in antibody–drug conjugates for breast cancer therapy by Víctor L. Cruz, Jorge Duro-Sánchez, Emma Franco-Mateos, Laura García-Estévez, José Pérez-García, María Gion, Laia Garrigós, Patricia Cortez, Cristina Saavedra, Patricia Gómez, Carolina Ortiz, Arantxa Aguinagalde, Javier Ramos, Javier Cortés, Juan F. Vega

Get full text

Biomarkers of palbociclib response in hormone receptor-positive advanced breast cancer from the PARSIFAL trial by Joan Albanell, Angelo Gámez Pozo, Carlos L. Arteaga, Meritxell Bellet, Federico Rojo, Abel González, Beatriz Bellosillo, Violeta Serra, Petra Gener, José Antonio Guerrero, Eileen Shimizu, Mario Mancino, Jose Rodríguez-Morató, Leonardo Mina, José Manuel Pérez-García, Javier Cortés, Antonio Llombart-Cussac

Get full text

Molecular determinants of response to neoadjuvant pembrolizumab plus chemotherapy in patients with high-risk, early-stage, triple-negative breast cancer: exploratory analysis of th... by Rebecca Dent, Javier Cortés, Yeon Hee Park, Eva Muñoz-Couselo, Sung-Bae Kim, Joohyuk Sohn, Seock-Ah Im, Esther Holgado, Theodoros Foukakis, Sherko Kümmel, Jennifer Yearley, Anran Wang, Michael Nebozhyn, Lingkang Huang, Razvan Cristescu, Petar Jelinic, Vassiliki Karantza, Peter Schmid

Get full text

Selective tubulin-binding drugs induce pericyte phenotype switching and anti-cancer immunity by Bo He, Kira H Wood, Zhi-jie Li, Judith A Ermer, Ji Li, Edward R Bastow, Suraj Sakaram, Phillip K Darcy, Lisa J Spalding, Cameron T Redfern, Jordi Canes, Mafalda Oliveira, Aleix Prat, Javier Cortes, Erik W Thompson, Bruce A Littlefield, Andrew Redfern, Ruth Ganss

Get full text

Ipatasertib combined with non-taxane chemotherapy for patients with previously treated advanced triple-negative breast cancer: the PATHFINDER phase IIa trial by Elena López-Miranda, Jose Manuel Pérez-García, María Gión, Nuria Ribelles, Patricia Cortez-Castedo, José Luis Alonso-Romero, María Martínez García, Santiago González-Santiago, Begoña Bermejo, Serafín Morales, Vicente Carañana, Laia Garrigós, Melissa Fernández-Pinto, Silvia García-Vicente, Alicia Garcia-Sanz, Arnau Mena-Molina, Olga Boix, Daniel Alcalá-López, Antonio Llombart-Cussac, Javier Cortés

Get full text

A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation by Marta Castroviejo‐Bermejo, Cristina Cruz, Alba Llop‐Guevara, Sara Gutiérrez‐Enríquez, Mandy Ducy, Yasir Hussein Ibrahim, Albert Gris‐Oliver, Benedetta Pellegrino, Alejandra Bruna, Marta Guzmán, Olga Rodríguez, Judit Grueso, Sandra Bonache, Alejandro Moles‐Fernández, Guillermo Villacampa, Cristina Viaplana, Patricia Gómez, Maria Vidal, Vicente Peg, Xavier Serres‐Créixams, Graham Dellaire, Jacques Simard, Paolo Nuciforo, Isabel T Rubio, Rodrigo Dienstmann, J Carl Barrett, Carlos Caldas, José Baselga, Cristina Saura, Javier Cortés, Olivier Déas, Jos Jonkers, Jean‐Yves Masson, Stefano Cairo, Jean‐Gabriel Judde, Mark J O'Connor, Orland Díez, Judith Balmaña, Violeta Serra

Get full text